ZA200800184B - Amino acid salts of rosiglitazone - Google Patents

Amino acid salts of rosiglitazone

Info

Publication number
ZA200800184B
ZA200800184B ZA200800184A ZA200800184A ZA200800184B ZA 200800184 B ZA200800184 B ZA 200800184B ZA 200800184 A ZA200800184 A ZA 200800184A ZA 200800184 A ZA200800184 A ZA 200800184A ZA 200800184 B ZA200800184 B ZA 200800184B
Authority
ZA
South Africa
Prior art keywords
rosiglitazone
amino acid
acid salts
salts
enantiomeric
Prior art date
Application number
ZA200800184A
Other languages
English (en)
Inventor
Werz Udo
Maas Gerhard
Stahl Heinrich
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of ZA200800184B publication Critical patent/ZA200800184B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Noodles (AREA)
  • Saccharide Compounds (AREA)
ZA200800184A 2005-07-22 2008-01-08 Amino acid salts of rosiglitazone ZA200800184B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005034406A DE102005034406A1 (de) 2005-07-22 2005-07-22 Neue Salze von Rosiglitazon

Publications (1)

Publication Number Publication Date
ZA200800184B true ZA200800184B (en) 2009-02-25

Family

ID=36870547

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800184A ZA200800184B (en) 2005-07-22 2008-01-08 Amino acid salts of rosiglitazone

Country Status (18)

Country Link
US (1) US20080207700A1 (ja)
EP (1) EP1907386B1 (ja)
JP (1) JP2009502760A (ja)
KR (1) KR20080032108A (ja)
CN (1) CN101228157A (ja)
AT (1) ATE469896T1 (ja)
AU (1) AU2006271863A1 (ja)
BR (1) BRPI0613686A2 (ja)
CA (1) CA2616031A1 (ja)
DE (2) DE102005034406A1 (ja)
EA (1) EA012594B1 (ja)
ES (1) ES2344662T3 (ja)
IL (1) IL188661A0 (ja)
NO (1) NO20080704L (ja)
NZ (1) NZ565159A (ja)
UA (1) UA92354C2 (ja)
WO (1) WO2007009799A1 (ja)
ZA (1) ZA200800184B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
AU2010232670B2 (en) 2009-04-03 2015-07-09 F. Hoffmann-La Roche Ag Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
TW201041888A (en) * 2009-05-06 2010-12-01 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
PE20121327A1 (es) 2009-11-06 2012-10-18 Plexxikon Inc Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello
PL2672967T3 (pl) 2011-02-07 2019-04-30 Plexxikon Inc Związki i sposoby modulacji kinaz i wskazania ku temu
US9030870B2 (en) * 2011-08-26 2015-05-12 Micron Technology, Inc. Threshold voltage compensation in a multilevel memory
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US9815777B2 (en) * 2013-09-22 2017-11-14 Jiva Pharma, Inc. Metformin salts to treat Type2 diabetes
CN107789352A (zh) * 2017-10-25 2018-03-13 桂林浩新科技服务有限公司 一种复方药物制剂及在制备治疗高血糖、高血脂的药物中的应用
CN109053718B (zh) * 2018-08-09 2022-06-03 天津理工大学 一种罗格列酮糖精盐及其制备方法
CN109053717B (zh) * 2018-08-09 2022-05-31 天津理工大学 一种罗格列酮龙胆酸盐及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0014006D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0019224D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021865D0 (en) * 2000-09-06 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
EP1349855B1 (en) * 2000-12-22 2006-08-23 Smithkline Beecham Plc 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
KR20040062965A (ko) * 2001-11-21 2004-07-09 스미스클라인비이참피이엘시이 로시글리타존 에디실레이트 및 항당뇨제로서의 그의 용도
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129851D0 (en) * 2001-12-13 2002-01-30 Smithkline Beecham Plc Novel compounds
WO2003050116A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130510D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2005023803A1 (en) * 2003-09-10 2005-03-17 Biocon Limited Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione

Also Published As

Publication number Publication date
AU2006271863A1 (en) 2007-01-25
NZ565159A (en) 2010-01-29
WO2007009799A1 (de) 2007-01-25
EP1907386A1 (de) 2008-04-09
JP2009502760A (ja) 2009-01-29
CN101228157A (zh) 2008-07-23
BRPI0613686A2 (pt) 2011-01-25
ATE469896T1 (de) 2010-06-15
US20080207700A1 (en) 2008-08-28
CA2616031A1 (en) 2007-01-25
IL188661A0 (en) 2008-08-07
ES2344662T3 (es) 2010-09-02
DE102005034406A1 (de) 2007-02-01
DE502006007113D1 (de) 2010-07-15
KR20080032108A (ko) 2008-04-14
EP1907386B1 (de) 2010-06-02
EA200800065A1 (ru) 2008-08-29
EA012594B1 (ru) 2009-10-30
NO20080704L (no) 2008-02-07
UA92354C2 (en) 2010-10-25

Similar Documents

Publication Publication Date Title
ZA200800184B (en) Amino acid salts of rosiglitazone
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
IL213342A0 (en) Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
IL236013A (en) Edamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase enzyme inhibitors
TW200745028A (en) Novel sulphonylpyrroles
GEP20104943B (en) Fused heterocyclic compounds useful as kinase modulators
TW200745027A (en) Novel sulphonylpyrroles
PT1761520E (pt) Inibidores de quinase
TW200640924A (en) VEGF-R2 inhibitors and methods
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
TW200716525A (en) Process for preparation of sulfamide derivatives
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
UA85505C2 (en) Kinase inhibitors
TW200624426A (en) BACE inhibitors
ZA200701137B (en) Triazolophthalazines
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
MX2008001538A (es) Aril piridinas y metodos para su uso.
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
DE502006009367D1 (de) Verfahren zur enantioselektiven enzymatischen Reduktion von Ketoverbindungen
EA200702584A1 (ru) Спиробензимидазолы как ингибиторы секреции соляной кислоты
PL2062881T3 (pl) Sposób wytwarzania N-(difenylometylo)piperazyn
IL189939A0 (en) Inhibitors of the hiv integrase enzyme
IL185076A0 (en) Process for the prepartion of enantiomerically pure 1-substituted-3-aminoalcohols